Peer Review History
| Original SubmissionMay 19, 2020 |
|---|
|
PONE-D-20-14863 Individualized Diet Improvement Program (iDip), an approach to weight loss by combining self-experimenting and self-monitoring using visual feedback: before and after study design PLOS ONE Dear Dr. Lee, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Be sure to take reviewer comments into consideration before resubmission. Please submit your revised manuscript by Dec 05 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols We look forward to receiving your revised manuscript. Kind regards, Jamie I. Baum, PhD Academic Editor PLOS ONE Additional Editor Comments: The title of the manuscript inaccurately describes the study. The paper needs the be re-written for syntax. ABSTRACT The abstract methodology is vague. What makes this study individualized as described in the title? What was the breakdown of male and female participants and average age? The results are descriptive, with no mention of p-values. Strong conclusions for n=12 finishing the iDip program. INTRODUCTION Lines 44-45: These are outdated programs that do not have as large of following as the did when first launched and the authors should include updated diet programs as examples. Several weight loss/energy reduction methods are described in the introduction. However, the title describes iDip as an individualized program and the introduction should address the importance of addressing individualized needs for successful weight loss. MATERIALS AND METHODS Lines 88-132 should come after participant recruitment and study design. This section is actually part of study/intervention design. -CONSORT guidelines should be followed -Were medications, alcohol intake, or tobacco use taken into consideration for recruitment? -No clear power analysis is presented. -Line 150- reference needed for attrition. -It is unclear how this study was individualized apart from the 3, 30-minute session offered over the 12 month intervention. Line 164: be specific beyond periodic. If the objective was to direct food intake based on protein and fiber density, then this feedback seems like it should be more regular than periodic. Line 183: again, be specific about periodic How often were participants providing feedback on home weighing The fiber and protein density plots seem difficult for the lay-person to understand. How was comprehension amongst participants assessed? How were FFQ collected? Digitally? RESULTS Exit survey could become supplemental material DISCUSSION -It is unclear how iDip is innovative. Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. In your Methods section, please provide additional information regarding some discrepancies found between your submission and the clinical trial protocol. For example, we note that the sample size in the protocol is reported to be 180; in the CT.gov registry, it is mentioned that 44 participants were recruited; while in the manuscript text, the sample size is 15. Please explain these discrepancies, and provide more detail on the how the sample size was calculated. Furthermore, we note that, according to the protocol, the dietary intake assessment should have been carried out at 0, 6 and 12 months; while in the manuscript, it is reported that it was carried out only at baseline and at 12 months. Also, please clearly state the dates for participant recruitment and follow-up. 3. Please include additional information regarding the survey or questionnaire used in the study and ensure that you have provided sufficient details that others could replicate the analyses. For instance, if you developed a questionnaire as part of this study and it is not under a copyright more restrictive than CC-BY, please include a copy, in both the original language and English, as Supporting Information. Moreover, please include more details on how the questionnaire was pre-tested, and whether it was validated. 4. Please note that according to our submission guidelines (http://journals.plos.org/plosone/s/submission-guidelines), outmoded terms and potentially stigmatizing labels should be changed to more current, acceptable terminology. For example: “Caucasian” should be changed to “white” or “of [Western] European descent” (as appropriate). 5. Thank you for submitting your clinical trial to PLOS ONE and for providing the name of the registry and the registration number. The information in the registry entry suggests that your trial was registered after patient recruitment began. PLOS ONE strongly encourages authors to register all trials before recruiting the first participant in a study. As per the journal’s editorial policy, please include in the Methods section of your paper: 1) your reasons for your delay in registering this study (after enrolment of participants started); 2) confirmation that all related trials are registered by stating: “The authors confirm that all ongoing and related trials for this drug/intervention are registered”. Please also ensure you report the date at which the ethics committee approved the study as well as the complete date range for patient recruitment and follow-up in the Methods section of your manuscript. 6. We note that you have stated that you will provide repository information for your data at acceptance. Should your manuscript be accepted for publication, we will hold it until you provide the relevant accession numbers or DOIs necessary to access your data. If you wish to make changes to your Data Availability statement, please describe these changes in your cover letter and we will update your Data Availability statement to reflect the information you provide. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #2: No ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: No Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: No Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The title is too long and should reflect the fact that it is a pilot study to test the feasibility of iDip on weight loss at 12 months. The initial protocol stated that, 30 participants would be in an intervention group and 30 in the wait-list group. The study design reported in this paper involved only 12 participants in a before-after comparison. Please explain. Rather than using the minimum sample size reported in other published studies, a formal power calculation should be provided to support the selected sample size. With more than one primary outcomes, what was the minimum effect size to detect post intervention? Data analysis only considered the paired t-tests on the differences before and after the intervention, and Pearson correlation on the associations between body weight and protein/fiber density. For a small sample of 12 participants who completed the intervention, have the authors checked the distribution of outcomes and considered non-parametric tests? The authors also compared the two groups of participants between the top and bottom half in weight loss at 12 months, what test was performed here? The repeated measures ANOVA reported in Figure 7 should also be mentioned in statistical analysis section. As this is not a randomised trial, baseline demographics and medical histories can be reported in Table 1 on the 12 participants who completed the intervention at 12 months. The two participants that discontinued the intervention can be described separately in text. It is also important to present baseline characteristics of the two groups of participants above or below 5% weight loss at 12 months and see how they may differ. The raw outcomes presented in Table 2 would be better presented as a full dataset at baseline and 12 months, since the primary and secondary outcomes were measured at these two time points on a total of 12 participants. There was no Table 3. For Table 4, I would suggest reporting median together with mean (SD) for a score of 1-7. The SE is redundant and should be removed. Both Pearson and Spearman correlation coefficients should be reported in a small sample. Note that mean weight loss is different from % weight loss, and the terms should not be used interchangeably. Reviewer #2: This paper reports on a small study evaluating the Individualized Diet Improvement Program (iDip) at 12 months. The 14 participants are only evaluated pre and post. Major 1. Study design This study lacks a comparison group which makes the authors' claims about the success of the program and the critical role of certain aspects of the program (the plot) unfounded. This evaluation is also only completed on a small group of people. If the sample were small, but the study design more rigorous, this alone would not be a major issue. However, in combination, it severely impairs any contribution to scientific knowledge. 2. Intervention It is unclear what exactly is novel and innovative about this weight management approach. The Protein-Fiber plot seems to be a big part of it. There is no evaluation of whether this plot was really used and all participants received it, so it is impossible to know its actual contribution to the program. The plot itself also appears to present only single foods and does not seem to account for whole diet or mixed foods (like casseroles) which is a major limitation. In the discussion, the study is described as innovative because it does not use calorie counting, specific food advice and is non-restrictive. But, ultimately the program applies a 25% energy restriction. In the discussion it says that participants were "encouraged to include all foods and self-select to moderate intake of foods with low protein and fiber densities". Given that the program included 19, 60-min meetings and 3 individual sessions delivered by a registered dietician, it would appear that this program is little more than a group-based, dietitian program. Despite suggestion that this program lacked detailed food or intake monitoring, the participants did monitor their food intake by completing 6 different 24h recalls. Although not a formal part of the program, with no comparator, it is impossible to know the effects of this. Previous studies have shown the importance of monitoring and how it alone can reduce intake. Minor 1. Why does the program include daily weighing? This can be a controversial recommendation that can result in obsessing over insignificant changes. 2. Figure 8 is an R output that may not be easily interpretable by many readers. 3. In the method, it states that dietary recalls were "periodically" completed. This needs to be specified. 4. The intervention and its specific novelty is not made particularly clear. Parts of the discussion provide better insight than the method, but this should be clear long before 5. The expenditure side of energy balance is not acknowledged in the introduction. 6. The discussion describes the diet as non-restrictive. It includes a 25% restriction. 7. There is no citation for the Power calculation. 8. There may exist an opportunity to explore how participants chose to restrict their diet and whether certain patterns were more successful. This could be more interesting as an outcome of the study and more of a contribution to the field. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
PONE-D-20-14863R1 A feasibility study to test a novel approach to dietary weight loss with a focus on assisting informed decision making in food selection PLOS ONE Dear Dr. Lee, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Sep 23 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, John W. Apolzan, PhD Academic Editor PLOS ONE Additional Editor Comments (if provided): As a reviewer notes, the tone of the manuscript needs to ensure that it is a feasibility study without a control group. The lack of a control group is a study limitation that needs to be stated. Please ensure the reviewer responses are addressed. Use of terms such as non-randomized and single arm trial would be beneficial throughout the manuscript including the conclusions. Further, the pilot or feasibility consort should be utilized. Also, the (TIDieR) checklist and guide should be used to describe the intervention. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #2: (No Response) Reviewer #3: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #2: No Reviewer #3: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #2: Yes Reviewer #3: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #2: Yes Reviewer #3: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #2: Yes Reviewer #3: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #2: Major Issues raised about the study design previously remain. Without a control group, the authors cannot conclude that the PF plot has efficacy over and above the methodological aspects of the study which included an extensive amount of dietary recall and FFQ and dietary coaching with a health professional. Further, as a feasibility study, it lacks any in-depth evaluation of the innovative components of the intervention (eg, the PF plots). The authors state that they could not find any overstatement in their conclusions. Two concrete examples are provided below. Each shows a lack of acknowledgement of study limitations while also being worded too strongly. 1) “The individualized PF plot played a critical role in dietary improvement and allowed participants to use the knowledge gained from education sessions to self select foods to increase or decrease.” Regular and intensive dietary recall and meetings with a dietician were much more likely the cause of this and the study design does not allow these to be teased apart. There is no evaluation of the possible mechanisms either. This statement suggests a linear process that has been demonstrated. The study provides no data to support this strongly worded statement. Furthermore, the ethics application notes that the purpose of the dietary recall is to “check adequacy of their diet and to troubleshoot if a participant is not losing weight effectively” so the recall process is seemingly a significant part of the overall intervention which is conveniently overlooked in favor of the PF plots in the paper conclusions. 2) “The dietary flexibility, self-selection of foods, and no need for daily calorie counting likely contributed to the low attrition.” Data do not support this. Once again with no comparison, it is impossible to know. The study design was very intensive and personal and more likely a contributor to high retention. If the study is a feasibility study and the main focus is on the PF plot, then there should have been an evaluation of this plot and how it was received, used, evaluated etc. Yet, questions in the Exit Survey do not ask anything about this. The authors failed to address this concern from the previous review. It remains difficult to determine the relevance of this core component in the absence of a comparator group and any thorough evaluation of these components. Minor SI Appendix 5: Blood pressure was measured according to the original protocol, why is this not presented? It is unclear what this means: “Registration was delayed due to lack of knowledge.” Reviewer #3: The authors have addressed the comments satisfactorily. I believe that calling the study "individualized diet..." sounds misleading because it appears to refer to personalized nutrition. While not a good term, it seems like it should be called "self-guided diet individualization..." ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #2: No Reviewer #3: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 2 |
|
A feasibility study to test a novel approach to dietary weight loss with a focus on assisting informed decision making in food selection PONE-D-20-14863R2 Dear Dr. Lee, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, John W. Apolzan, PhD Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: |
| Formally Accepted |
|
PONE-D-20-14863R2 A feasibility study to test a novel approach to dietary weight loss with a focus on assisting informed decision making in food selection Dear Dr. Lee: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. John W. Apolzan Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .